Extracorporeal Membrane Oxygenation (ECMO) Market By Reports And Data
                     Extracorporeal 
Membrane 
Oxygenation 
(ECMO) Market 
To Reach USD 
371.8 Million By 
2027
              Markett  Summary
Increasing prevalence of infectious, cardiovascular and respiratory diseases, growing adoption of ECMO in 
lung transplantation procedures, growth in the number of ECMO centers, increasing survival rates with ECMO 
and increasing strategic initiatives such as product launch or collaboration are key factors contributing to high 
CAGR of Extracorporeal Membrane Oxygenation (ECMO) Market during forecast period.
Market Size – USD 267.1 Million in 2019, Market Growth - CAGR of 4.2% Market Trends –Technological 
advancements in ECMO machine
According to the current analysis of Reports and Data, the global 
Extracorporeal Membrane Oxygenation (ECMO) market was valued at USD 267.1 million in 2019 and is 
expected to reach USD 371.8 million by the year 2027, at a CAGR of 4.2%. Extracorporeal membrane 
oxygenation  is a treatment provided for COVID-19, cardiac and respiratory diseases. Increasing the 
prevalence of target diseases (such as COVID-19, cardiovascular diseases and respiratory diseases), 
technological advancements, and increasing extracorporeal membrane oxygenation centers across the globe 
are some of the factors driving the market growth. It is estimated that in the U.S., approximately 1,055,000 
individuals will have coronary diseases, including 720,000 new and 335,000 recurrent coronary events. The 
number of artificial respiration via the help of the device in a developed nation such as the U.S. from the past 
decade is constantly on rise. With rising technological innovations improved survival rate with extracorporeal 
membrane oxygenation is another major factor that supports the spread of the adoption of extracorporeal 
membrane oxygenation in case of medical emergencies such as COVID-19 cases.  In South Korea it has been 
observed that the inpatient with Extracorporeal membrane oxygenation therapy for respiratory failure had  
improved survival rate from 30.8% to 35.9%.
www.reportsanddata.com
Further key findings from the report suggest
• Various organizations and research institutes are engaged in clinical trials of the extracorporeal 
membrane oxygenation for cardiac and respiratory diseases. For instance, NHS ECMO completed 
the study of the ECMO service for adults with respiratory failure. Central Hospital, Nancy, France 
is engaged in studying the efficacy of Venoarterial Extracorporeal Membrane Oxygenation prior 
the left ventricular assist device implantation
• Based on end use segment, pediatric is expected to account for the CAGR 3.6% of the global 
extracorporeal membrane oxygenation market, as growing incidences of birth defect and 
premature birth across the world and raising public awareness about the technologically 
advanced respiratory support
• Asia Pacific is expected to grow at the highest rate. Developing nations such China, and India are 
likely to witness high growth due to high prevalence of cardiac and pulmonary diseases, 
increased healthcare expenditure and growing R&D investment
• High cost of the the procedure and lack of skilled personnel are the key factors likely to hamper 
growth of the extracorporeal membrane oxygenation market
• Recently, Terumo and Marker Therapeutics received FDA approval for a blood purification and 
oxygenation system in the treatment of COVID-19 infection. Terumo’s Spectra Optia apheresis 
system works with the Marker Therapeutics’ Depuro D2000 adsorption cartridges. It reduces the 
number of cytokines and other inflammatory blood proteins that control a cell’s immune 
response then filter the blood and return it to the patient. According to the FDA the proteins 
that are removed are typically elevated during infections, leading to severe inflammation, rapidly 
progressive shock, respiratory failure, organ failure and death.
              Markett  Summary
Key Players:   
Getinge Group (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Corporation (Japan), 
MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. 
(Germany), and EUROSETS S.r.l. (Italy).
Segmentation:
For the purpose of this report, Reports and Data has segmented the Extracorporeal Membrane Oxygenation  market on the 
basis of type, component, application, end use and region:
Type Outlook (Revenue, USD Million; 2017-2027)
• Venovenous ECMO
• Venoarterial ECMO
• Arteriovenous ECMO
Application Outlook (Revenue, USD Million; 2017-2027)
• Congenital Diaphragmatic Hernia (CDH)
• Birth Defects of the Heart
• Meconium Aspiration Syndrome (MAS)
• Severe Pneumonia
• Severe Air Leak Problems
• Severe High Blood Pressure in the Arteries of the Lungs (PPHN)
• Others
To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://
www.reportsanddata.com/sample-enquiry-form/2465
www.reportsanddata.com
              Markett  Summary
Component Outlook (Revenue, USD Million; 2017-2027)
• Pumps
• Cannula
• Oxygenators
• Gas Blender
• Heat Exchanger
• Pressure Monitor
• Bladder Reservoir
• Controller
• Gas Cylinder
• Others
End Use Outlook (Revenue, USD Million; 2017-2027)
• Pediatric
• Adult
Regional Outlook (Revenue in USD Million; 2017-2027)
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Grab Your Report at an Impressive Discount! Please Click Here :  https://
www.reportsanddata.com/discount-enquiry-form/2465
www.reportsanddata.com
              The  reportt  emphasiizes  tthe  ffollllowiing  key  questtiions::
Q.1.What are the most lucrative and promising growth prospects for the market?
Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects 
come into play in this advancement?
Q.3.Which geographies are estimated to exhibit the highest growth and the underlying 
causes?
Q.4.Which factors are impacting the future of the market and what are the driving 
factors?
Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast 
period?
www.reportsanddata.com
About Us
Reports and Data is a market research and consulting company that provides 
syndicated research reports, customized research reports, and consulting services. 
Our solutions purely focus on your purpose to locate, target and analyze consumer 
behavior shifts across demographics, across industries and help client’s make a 
smarter business decision. We offer market intelligence studies ensuring relevant 
and fact-based research across a multiple industries including Healthcare, 
Technology, Chemicals, Power, and Energy. We consistently update our research 
offerings to ensure our clients are aware about the latest trends existent in the 
market. Reports and Data has a strong base of experienced analysts from varied 
areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]